Idexx LaboratoriesIDXX is the IBD Stock of the Day for Friday. Shares of the maker of animal diagnostics tools are trading ...

Ratings for IDEXX Laboratories (NASDAQ:IDXX) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview ...

Across the recent three months, 4 analysts have shared their insights on IDEXX Laboratories (NASDAQ:IDXX), expressing a variety of opinions spanning from bullish to bearish. The table below summarizes ...

Idexx LaboratoriesIDXX easily beat second-quarter expectations Monday as the animal-health player continued benefiting from the "puppy boom" of 2020. Maine-based Idexx sells lab equipment for ...

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Monday posted fourth-quarter earnings and revenue that beat market expectations and issued initial financial guidance for 2025. The Westbrook-based maker of ...

IDEXX Laboratories, a healthcare supplier specializing in veterinary health diagnostics and research, is a potential high-performing compounder due to its wide-moat business model, anti-cyclical ...

Aug 4 (Reuters) - IDEXX Laboratories (IDXX.O), opens new tab raised its full-year profit and revenue forecasts on Monday after reporting better-than-expected second-quarter results, sending its shares ...

IDEXX Laboratories (NASDAQ: IDXX) has outperformed the market over the past 10 years by 11.91% on an annualized basis producing an average annual return of 25.31%. Currently, IDEXX Laboratories has a ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026 ...

IDEXX Labs offers veterinary diagnostic instruments, rapid assay test kits, reference lab services, water quality testing products, and veterinary practice management software. The company generates ...

IDEXX Q4 adjusted EPS rose 10% YoY to $2.53, beating the $2.40 estimate. Revenue grew 6% to $954.3M, surpassing the $934.99M consensus. 2025 revenue guidance set at $4.055B–$4.170B vs. $4.14B ...

Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...